During the past decade, Uvea Klinika, S.R.O. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Uvea Klinika, S.R.O." are "Cataract" (1 trials), "Macular Edema" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Uvea Klinika, S.R.O." in a lesser frequency.

Most popular intervention types in "Uvea Klinika, S.R.O." are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (1 trials), "Chloroprocaine 3%" (1 trials), "KSI-301" (1 trials), "Sham Procedure" (1 trials) and "Tetracaine 0.5%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uvea Klinika, S.R.O." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Uvea Klinika, S.R.O.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Uvea Klinika, S.R.O., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Uvea Klinika, S.R.O., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".